dnsp 11 peptide an 11-mer peptide from the proGDNF domain - DSIPpeptide DNSP-11 is an 11-mer peptide Unveiling the Potential of DNSP-11 Peptide: A Neuroprotective Agent

DNSP-11 buy The field of neuroscience is continuously exploring novel therapeutic avenues, and the dnsp 11 peptide has emerged as a significant area of interest. This 11-mer peptide, derived from the prodomain of the human GDNF family, specifically the glial cell line-derived neurotrophic factor, has demonstrated remarkable neurotrophic and neuroprotective properties, particularly concerning dopamine neurons(A) DNSP-11 (filled) is an 11 amino acid sequence present .... Its designation, Dopamine neuron stimulating peptide-11 (DNSP-11), directly reflects its primary observed function作者：MJ Stenslik·2015·被引用次数：31—These studies support thatDNSP-11 can be delivered intranasallyand maintain its neuroactive properties in both normal rats and in a unilateral 6-OHDA rat ....

Research indicates that DNSP-11 is the first peptide identified from the prodomain of GDNF to exhibit trophic-like actions in vivo.DNSP‐11 reduces 6‐OHDA‐induced caspase 3/7 activation ... This 11 amino acid peptide is a synthetic, amidated molecule, comprising 11 consecutive amino acid residues from the proregion of GDNF. Its origin as a predicted endopeptidase cleavage product from the human GDNF prosequence underscores its biological relevance. Studies have shown that DNSP-11 supports the survival of fetal mesencephalic neurons in vitro作者：JL Fuqua·2014·被引用次数：17—Dopamine neuron stimulating peptide-11 (DNSP-11) is a synthetic, amidated 11-amino acid neuroactive peptide derived from the human GDNF pro-domain (Bradley et .... Furthermore, in vivo administration of DNSP-11 has been shown to increase dopamine and dopamine metabolite tissue levels in the substantia nigra of rats, suggesting a direct impact on the dopaminergic system.

A key aspect of DNSP-11 peptide research revolves around its neuroprotective capabilities. Investigations have shown that DNSP-11 protects human dopaminergic neuroblastoma cells against cell death induced by various stressorsDNSP-11 Peptide ≥98% (HPLC), powder. Notably, it provides protection against staurosporine and 6-hydroxydopamine-induced cell death. This protective effect is partly mediated by the activation of neuroprotective ERK signaling. The dynamic changes in dopamine neuron function after DNSP-11 treatment highlight its potential to modulate neuronal activity and resilience.DNSP-11 is an 11-mer peptidefrom the pro-GDNF domain with neurotrophic and neuroprotective activity toward dopamine neurons.

The methodology and effects of administering DNSP-11 are also being actively studiedGDNF - glial cell derived neurotrophic factor. One promising delivery route explored is intranasal administration. Studies suggest that DNSP-11 can be delivered intranasally and maintain its neuroactive properties within the central nervous system (CNS).Dynamic changes in dopamine neuron function after DNSP ... This non-invasive approach offers a potential avenue for easier therapeutic application. Research has demonstrated that DNSP-11 can be delivered to the CNS intranasally, maintaining its neuroactive properties on the nigrostriatal system in animal models2010年3月1日—... (DNSP-11),an 11-mer peptide from the proGDNF domain. In vitro, DNSP-11 supports the survival of fetal mesencephalic neurons, increasing .... The methodology and effects of repeated intranasal delivery of DNSP-11 are crucial for understanding its therapeutic potential.

The DNSP-11 peptide is available as a high-purity research compound, often with purity levels of ≥98% as determined by HPLC. It is typically supplied as a trifluoroacetate salt and can be purchased in various quantities, such as 1 mg or 5 mg, catering to advanced scientific exploration in neurobiology. The availability of DNSP-11 for sale underscores its role as a specialized research peptide.

The broader implications of DNSP-11 extend to neurological conditions characterized by dopamine neuron degeneration, such as Parkinson's disease. Targeting the hypothalamic a11 nucleus and exploring neuroprotective effects of brain-gut peptides are related areas of research that highlight the ongoing scientific endeavor to understand and treat neurodegenerative disorders. While DNSP-11 is a research chemical and not a clinically approved drug, its demonstrated neurotrophic and protective actions make it a compelling subject for further investigation into potential therapeutic strategies for conditions affecting the dopaminergic system. The exploration of peptides in neurology, including compounds like DNSP-11, represents a dynamic frontier in the quest for effective treatments.